Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas

Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas

Background/purpose: Cancer stem cells (CSCs) have been known to be implicated in tumorigenesis, metastasis, and drug resistance in oral squamous cell carcinomas (OSCC). In this study, we aimed to investigate whether magnolol, a polyphenolic component derived from Magnolia officinalis, exhibited the...

Full description

Bibliographic Details
Main Authors:	Chih-Yu Peng, Cheng-Chia Yu, Chun-Chung Huang, Yi-Wen Liao, Pei-Ling Hsieh, Pei-Ming Chu, Chuan-Hang Yu, Shih-Shen Lin
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Journal of the Formosan Medical Association
Subjects:	Oral squamous cell carcinomas Magnolol Cancer stem cells
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664621000267

Similar Items

Magnolol ameliorates the accumulation of reactive oxidative stress and inflammation in diabetic periodontitis
by: Chia-Ming Liu, et al.
Published: (2021-07-01)

Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration
by: Chung-Ping Yu, et al.
Published: (2021-12-01)

Synthesis, anti-aging and mechanism of magnolol derivatives
by: Xinxin Pang, et al.
Published: (2023-05-01)

Magnolol Induces the Extrinsic/Intrinsic Apoptosis Pathways and Inhibits STAT3 Signaling-Mediated Invasion of Glioblastoma Cells
by: Po-Fu Yueh, et al.
Published: (2021-12-01)

Magnolol Triggers Caspase-Mediated Apoptotic Cell Death in Human Oral Cancer Cells through JNK1/2 and p38 Pathways
by: Yi-Tzu Chen, et al.
Published: (2021-09-01)

Enhanced oral bioavailability of magnolol via mixed micelles and nanosuspensions based on Soluplus®-Poloxamer 188
by: Guoyuan Li, et al.
Published: (2020-01-01)

Pharmaceutical Evaluation of Honokiol and Magnolol on Apoptosis and Migration Inhibition in Human Bladder Cancer Cells
by: Hisao-Hsien Wang, et al.
Published: (2020-11-01)

In vitro inhibitory activities of magnolol against Candida spp.
by: Zhou PR, et al.
Published: (2017-09-01)

Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
by: Yiping Lin, et al.
Published: (2021-03-01)

Cardiovascular protection of magnolol: cell-type specificity and dose-related effects
by: Ho Jennifer, et al.
Published: (2012-07-01)

Influence of Magnolol on the Secretion of α-Toxin by Staphylococcus aureus
by: Xu-Ming Deng, et al.
Published: (2010-03-01)

Antiandrogenic activity and bioavailability of magnolol analogs – A potential for prostate cancer therapeutics
by: Agneta Oskarsson, et al.
Published: (2023-11-01)

Mechanistic insights of magnolol antimicrobial activity against Mycoplasma using untargeted metabolomic analyses
by: Hu Qiao, et al.
Published: (2023-12-01)

The Use of Triphenyl Phosphonium Cation Enhances the Mitochondrial Antiplatelet Effect of the Compound Magnolol
by: Francisca Tellería, et al.
Published: (2023-01-01)

Semi-Synthesis and In Vitro Anti-Cancer Evaluation of Magnolol Derivatives
by: Xiao-Long Sun, et al.
Published: (2021-07-01)

Fenofibrate diminishes the self-renewal and metastasis potentials of oral carcinoma stem cells through NF-κB signaling
by: Tzu-Rong Su, et al.
Published: (2022-10-01)

Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization
by: Jia Shen, et al.
Published: (2017-07-01)

Amorphous solid dispersion preparation via coprecipitation improves the dissolution, oral bioavailability, and intestinal health enhancement properties of magnolol
by: Jia Cao, et al.
Published: (2023-06-01)

Evaluating the Magnolol Anticancer Potential in MKN-45 Gastric Cancer Cells
by: Mahsa Naghashpour, et al.
Published: (2023-02-01)

Magnolol and Honokiol: Two Natural Compounds with Similar Chemical Structure but Different Physicochemical and Stability Properties
by: Iris Usach, et al.
Published: (2021-02-01)

Chitosan-Based Functional Films Integrated with Magnolol: Characterization, Antioxidant and Antimicrobial Activity and Pork Preservation
by: Xueying Song, et al.
Published: (2021-07-01)

Acid-degradable magnolol-containing polymeric prodrug micelles for enhanced gastric cancer therapy
by: Dongshi Liang, et al.
Published: (2023-11-01)

Protein Kinase B Inactivation Is Associated with Magnolol-Enhanced Therapeutic Efficacy of Sorafenib in Hepatocellular Carcinoma In Vitro and In Vivo
by: Jiann-Hwa Chen, et al.
Published: (2019-12-01)

Magnolol, a Natural Polyphenol, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice
by: Ling Zhao, et al.
Published: (2017-07-01)

Enhanced Oral Bioavailability of the Pharmacologically Active Lignin Magnolol via Zr-Based Metal Organic Framework Impregnation
by: Joshua H. Santos, et al.
Published: (2020-05-01)

Beneficial effect of honokiol and magnolol on polyol pathway and oxidative stress parameters in the testes of diabetic rats
by: Katarzyna Szałabska-Rąpała, et al.
Published: (2024-03-01)

Honokiol/Magnolol-Loaded Self-Assembling Lecithin-Based Mixed Polymeric Micelles (lbMPMs) for Improving Solubility to Enhance Oral Bioavailability
by: Lin HL, et al.
Published: (2021-01-01)

Anti-Inflammatory and Antioxidant Properties of Carvacrol and Magnolol, in Periodontal Disease and Diabetes Mellitus
by: Georgiana Ioana Potra Cicalău, et al.
Published: (2021-11-01)

The Development of Magnolol-Loaded Intravenous Emulsion with Low Hepatotoxic Potential
by: Aleksandra Gostyńska, et al.
Published: (2023-09-01)

Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression
by: Youn-Hwan Hwang, et al.
Published: (2018-07-01)

Magnolol, A Novel Antagonist of Thrombin and PAR-1, Inhibits Thrombin-Induced Connective Tissue Growth Factor (CTGF) Expression in Vascular Smooth Muscle Cells and Ameliorate Pathogenesis of Restenosis in Rats
by: Wen-Chin Ko, et al.
Published: (2020-12-01)

Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway
by: Xuechu Wang, et al.
Published: (2023-05-01)

Assessing the Antioxidant Benefits of Topical Carvacrol and Magnolol Periodontal Hydrogel Therapy in Periodontitis Associated with Diabetes in Wistar Rats
by: Georgiana Ioana Potra Cicalău, et al.
Published: (2023-12-01)

Magnolol as a Potential Anticancer Agent: A Proposed Mechanistic Insight
by: Xiaofeng Wang, et al.
Published: (2022-09-01)

Sulfation and Its Effect on the Bioactivity of Magnolol, the Main Active Ingredient of <i>Magnolia Officinalis</i>
by: Cong Xie, et al.
Published: (2022-09-01)

CYP3A Excipient-Based Microemulsion Prolongs the Effect of Magnolol on Ischemia Stroke Rats
by: Jiun-Wen Guo, et al.
Published: (2020-08-01)

Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction
by: Chia-Ming Liu, et al.
Published: (2017-01-01)

Identification and Validation of Magnolol Biosynthesis Genes in <i>Magnolia officinalis</i>
by: Yue Yang, et al.
Published: (2024-01-01)

Dietary magnolol inclusion improves the antioxidant and immune responses, and resistance to Aeromonas hydrophila in genetically improved farmed tilapia (Oreochromis niloticus)
by: Han Huang, et al.
Published: (2022-04-01)

Synthesis, Characterization and Biological Evaluation of Magnolol and Honokiol Derivatives with 1,3,5-Triazine of Metformin Cyclization
by: Cui Ren, et al.
Published: (2020-12-01)